Teaching Responsibility
LJMU Schools involved in Delivery:
Pharmacy & Biomolecular Sciences
Learning Methods
Lecture
Online
Tutorial
Workshop
Module Offerings
7203CPPHAR-SEP-CTY
Aims
To develop, evaluate and apply knowledge relating to the medicines optimisation of long-term conditions commonly encountered in primary care and community pharmacy in individual patients and groups of patients
Learning Outcomes
1.
Develop the ability to choose, or make recommendations on, the most appropriate treatment for long-term conditions by applying clinical knowledge, national and/or local guidance to the critical review of medication regimes
2.
Manage, or support, the safe and effective use of medicines for individual patients or groups of patients through holistic consideration of health and social care issues
3.
Critically evaluate and critique medicines use in individual patients or groups of patients, considering relevant evidence, guidelines, and patient factors.
Module Content
Outline Syllabus:
Principles of medicines optimisation in chronic conditions Therapeutic management and medicines optimisation in specified chronic conditions, which may include: Chronic kidney disease Maintenance treatment of asthma Maintenance treatment of chronic obstructive pulmonary disease Infective complications of chronic conditions Anaemia Dementia Chronic pain Anxiety & Depression Hypertension Heart failure Rheumatoid Arthritis Osteoarthritis Recognising limitations, and referring patients for specialist care appropriately
Principles of medicines optimisation in chronic conditions Therapeutic management and medicines optimisation in specified chronic conditions, which may include: Chronic kidney disease Maintenance treatment of asthma Maintenance treatment of chronic obstructive pulmonary disease Infective complications of chronic conditions Anaemia Dementia Chronic pain Anxiety & Depression Hypertension Heart failure Rheumatoid Arthritis Osteoarthritis Recognising limitations, and referring patients for specialist care appropriately
Module Overview:
This module is studied in the PgCert, PgDip and MSc. The module considers the medicines optimisation of long-term conditions commonly encountered in primary care and community pharmacy in individual patients and groups of patients.
This module is studied in the PgCert, PgDip and MSc. The module considers the medicines optimisation of long-term conditions commonly encountered in primary care and community pharmacy in individual patients and groups of patients.
Additional Information:
This module is also offered as a L7 CPD programme (36441) with the following specification: CPD programme to be made available from September 2020 No specific benchmarks are available for this module, but the learning outcomes at least meet, if not exceed, those stipulated in the relevant qualification descriptors for a higher education qualification at level 7 (Master's degree characteristics) as defined by QAA UK Quality code. The LJMU University regulations that the programme(s) will be operating within are written in line with the wider QAA UK Quality Code. The programme(s) have also been designed following consultation with reference to specific aspects of the QAA UK Quality Code: The programme has been written in line with the LJMU Academic Framework (https://www.ljmu.ac.uk/about-us/public-information/academic-quality-and-regulations/academic-framework). The programme has been designed to ensure that learning and assessment are appropriate to a FHEQ Level 7 standard. Learning outcomes are assessed through a number of activities, but these are tailored to maximise the application of knowledge wherever possible and thus require recall and synthesis of complex information on a range of topics in order for the student to be successful. The programme will begin each March or September, with teaching and learning activities (and assessments) spanning the full 11 months to the following February/August for students undertaking the programme. Attendance is required for study days. The students have access to a module Canvas site and the University's other range of electronic support such as access to the electronic library facilities. The module content is regularly updated on the Canvas site including contemporary reading lists and links to journal articles. All students are assigned a personal Tutor for support and guidance through the module, this maybe via email or online tutorials. There is also access to the module leader through phone contact and email. CPD guide and Key Information are provided. The criteria for admission to the module require that candidates meet the criteria for admission to the MSc/PgDip/PgCert Clinical Pharmacy Primary care and community pharmacy programme (36435) The final award is Certificate of Professional Development in Medicines Optimisation for Long Term Conditions, 20 credits at Level 7. The module forms part of the MSc/PgDip/PgCert Clinical Pharmacy Primary care and community pharmacy programme (36435). The methods for improving the quality and standards of learning are as follows: • Continuous monitoring exercise; • Liaison and feedback from the students; • Reports from External Examiner; • Programme team ensuring the module reflects the values of the current teaching and learning strategy; • Module leader and/or specialist clinical pharmacists author updating knowledge and skills to ensure these remain current and relevant. The module is included in the programme specification for the suite of Clinical Pharmacy programmes for continuous monitoring and external examining purposes.
This module is also offered as a L7 CPD programme (36441) with the following specification: CPD programme to be made available from September 2020 No specific benchmarks are available for this module, but the learning outcomes at least meet, if not exceed, those stipulated in the relevant qualification descriptors for a higher education qualification at level 7 (Master's degree characteristics) as defined by QAA UK Quality code. The LJMU University regulations that the programme(s) will be operating within are written in line with the wider QAA UK Quality Code. The programme(s) have also been designed following consultation with reference to specific aspects of the QAA UK Quality Code: The programme has been written in line with the LJMU Academic Framework (https://www.ljmu.ac.uk/about-us/public-information/academic-quality-and-regulations/academic-framework). The programme has been designed to ensure that learning and assessment are appropriate to a FHEQ Level 7 standard. Learning outcomes are assessed through a number of activities, but these are tailored to maximise the application of knowledge wherever possible and thus require recall and synthesis of complex information on a range of topics in order for the student to be successful. The programme will begin each March or September, with teaching and learning activities (and assessments) spanning the full 11 months to the following February/August for students undertaking the programme. Attendance is required for study days. The students have access to a module Canvas site and the University's other range of electronic support such as access to the electronic library facilities. The module content is regularly updated on the Canvas site including contemporary reading lists and links to journal articles. All students are assigned a personal Tutor for support and guidance through the module, this maybe via email or online tutorials. There is also access to the module leader through phone contact and email. CPD guide and Key Information are provided. The criteria for admission to the module require that candidates meet the criteria for admission to the MSc/PgDip/PgCert Clinical Pharmacy Primary care and community pharmacy programme (36435) The final award is Certificate of Professional Development in Medicines Optimisation for Long Term Conditions, 20 credits at Level 7. The module forms part of the MSc/PgDip/PgCert Clinical Pharmacy Primary care and community pharmacy programme (36435). The methods for improving the quality and standards of learning are as follows: • Continuous monitoring exercise; • Liaison and feedback from the students; • Reports from External Examiner; • Programme team ensuring the module reflects the values of the current teaching and learning strategy; • Module leader and/or specialist clinical pharmacists author updating knowledge and skills to ensure these remain current and relevant. The module is included in the programme specification for the suite of Clinical Pharmacy programmes for continuous monitoring and external examining purposes.